These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18180345)

  • 1. Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections.
    Fritsche TR; Rhomberg PR; Sader HS; Jones RN
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1187-9. PubMed ID: 18180345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections.
    Fritsche TR; Rhomberg PR; Sader HS; Jones RN
    J Antimicrob Chemother; 2008 May; 61(5):1092-8. PubMed ID: 18310135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity.
    Sader HS; Fedler KA; Rennie RP; Stevens S; Jones RN
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3112-8. PubMed ID: 15273128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models.
    Rubinchik E; Dugourd D; Algara T; Pasetka C; Friedland HD
    Int J Antimicrob Agents; 2009 Nov; 34(5):457-61. PubMed ID: 19524411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus.
    Fritsche TR; Rhomberg PR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):399-403. PubMed ID: 18178361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009).
    Pfaller MA; Castanheira M; Messer SA; Moet GJ; Jones RN
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):278-83. PubMed ID: 20846808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.
    Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Ng KP; Colombo A; Finquelievich J; Barnes R; Wadula J;
    J Clin Microbiol; 2008 Mar; 46(3):842-9. PubMed ID: 18199791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of Candida species isolated from blood culture to some antifungal agents.
    Citak S; Ozçelik B; Cesur S; Abbasoğlu U
    Jpn J Infect Dis; 2005 Feb; 58(1):44-6. PubMed ID: 15728993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anidulafungin: when and how? The clinician's view.
    George J; Reboli AC
    Mycoses; 2012 Jan; 55(1):36-44. PubMed ID: 21668526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on antifungal resistance in Aspergillus and Candida.
    Arendrup MC
    Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():42-8. PubMed ID: 24372701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-hydroxyisocaproic acid is fungicidal for Candida and Aspergillus species.
    Sakko M; Moore C; Novak-Frazer L; Rautemaa V; Sorsa T; Hietala P; Järvinen A; Bowyer P; Tjäderhane L; Rautemaa R
    Mycoses; 2014 Apr; 57(4):214-21. PubMed ID: 24125484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter-related fungemia due to fluconazole-resistant Candida nivariensis.
    Fujita S; Senda Y; Okusi T; Ota Y; Takada H; Yamada K; Kawano M
    J Clin Microbiol; 2007 Oct; 45(10):3459-61. PubMed ID: 17652473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal susceptibility of 1000 Candida bloodstream isolates to 5 antifungal drugs: results of a multicenter study conducted in São Paulo, Brazil, 1995-2003.
    da Matta DA; de Almeida LP; Machado AM; Azevedo AC; Kusano EJ; Travassos NF; Salomão R; Colombo AL
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):399-404. PubMed ID: 17240110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.
    Pfaller MA; Diekema DJ
    J Clin Microbiol; 2004 Oct; 42(10):4419-31. PubMed ID: 15472288
    [No Abstract]   [Full Text] [Related]  

  • 16. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.
    Cuenca-Estrella M; Gomez-Lopez A; Mellado E; Monzon A; Buitrago MJ; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2009 May; 53(5):2192-5. PubMed ID: 19223630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
    Ozcan SK; Mutlu B; Dündar D; Willke A
    Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathelicidin-inspired antimicrobial peptides as novel antifungal compounds.
    van Eijk M; Boerefijn S; Cen L; Rosa M; Morren MJH; van der Ent CK; Kraak B; Dijksterhuis J; Valdes ID; Haagsman HP; de Cock H
    Med Mycol; 2020 Nov; 58(8):1073-1084. PubMed ID: 32236485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
    Borg-von Zepelin M; Kunz L; Rüchel R; Reichard U; Weig M; Gross U
    J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.